lupus treatment
-
Phase 2 JASMINE Study Shows Nipocalimab Reduces Disease Activity in Adults with Systemic Lupus Erythematosus
.
Posted on June 3, 2026 Pharmaceutical company Johnson & Johnson announced new late-breaking results from its Phase 2 JASMINE study showing that investigational therapy nipocalimab significantly reduced disease activity in adults living with…